All In MedTech

Device Trial Radar · NCT06947447

WatchPAT SpO2 Validation Study

Last checked: Nov 20, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

24

Actual

Start

Apr 21, 2025

Primary completion

May 2, 2025

Study completion May 2, 2025

Sponsor

Lead sponsor
Itamar-Medical, IsraelNot on our public-company list
Sponsor type
Industry
Collaborators
Element Materials Technology
First posted
Apr 27, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Validate the SpO2 accuracy of the WatchPAT compared to arterial blood CO-Oximetry

Conditions

  • Healthy

Interventions

  • No interventionDevice

    Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SpO2 AccuracyTime frame: April-May 2025

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Element Materials Technology

    Louisville, Colorado

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.